Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients

PURPOSE OF REVIEW: In this review, we aim to summarize the evolution of care for the solid organ transplant recipient (SOTR) with COVID-19 disease, based on the current published guidelines and our center’s experience. RECENT FINDINGS: Oral antiviral medications and monoclonal antibodies are now use...

Descripción completa

Detalles Bibliográficos
Autores principales: Sigler, Rachel, Chen, Victor, Law, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Kidney Transplantation (ML Henry and R Pelletier, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154200/
https://www.ncbi.nlm.nih.gov/pubmed/35669887
http://dx.doi.org/10.1007/s40472-022-00368-z
_version_ 1784717993326936064
author Sigler, Rachel
Chen, Victor
Law, Nancy
author_facet Sigler, Rachel
Chen, Victor
Law, Nancy
author_sort Sigler, Rachel
collection PubMed
description PURPOSE OF REVIEW: In this review, we aim to summarize the evolution of care for the solid organ transplant recipient (SOTR) with COVID-19 disease, based on the current published guidelines and our center’s experience. RECENT FINDINGS: Oral antiviral medications and monoclonal antibodies are now used with the goal to prevent severe disease. Immunomodulating drugs in addition to antivirals have been used in the treatment of severe COVID-19. SUMMARY: With the ongoing pandemic and unique challenges posed by the SOTR, understanding the risk and advancing management and treatment of COVID-19 infections are imperative to the successful care of a transplant recipient. There are many ongoing clinical trials being conducted in hopes of developing novel therapeutics towards COVID-19.
format Online
Article
Text
id pubmed-9154200
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-91542002022-06-02 Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients Sigler, Rachel Chen, Victor Law, Nancy Curr Transplant Rep Kidney Transplantation (ML Henry and R Pelletier, Section Editor) PURPOSE OF REVIEW: In this review, we aim to summarize the evolution of care for the solid organ transplant recipient (SOTR) with COVID-19 disease, based on the current published guidelines and our center’s experience. RECENT FINDINGS: Oral antiviral medications and monoclonal antibodies are now used with the goal to prevent severe disease. Immunomodulating drugs in addition to antivirals have been used in the treatment of severe COVID-19. SUMMARY: With the ongoing pandemic and unique challenges posed by the SOTR, understanding the risk and advancing management and treatment of COVID-19 infections are imperative to the successful care of a transplant recipient. There are many ongoing clinical trials being conducted in hopes of developing novel therapeutics towards COVID-19. Springer International Publishing 2022-05-31 2022 /pmc/articles/PMC9154200/ /pubmed/35669887 http://dx.doi.org/10.1007/s40472-022-00368-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Kidney Transplantation (ML Henry and R Pelletier, Section Editor)
Sigler, Rachel
Chen, Victor
Law, Nancy
Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients
title Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients
title_full Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients
title_fullStr Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients
title_full_unstemmed Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients
title_short Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients
title_sort evolution of clinical care in covid-infected solid organ transplant recipients
topic Kidney Transplantation (ML Henry and R Pelletier, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154200/
https://www.ncbi.nlm.nih.gov/pubmed/35669887
http://dx.doi.org/10.1007/s40472-022-00368-z
work_keys_str_mv AT siglerrachel evolutionofclinicalcareincovidinfectedsolidorgantransplantrecipients
AT chenvictor evolutionofclinicalcareincovidinfectedsolidorgantransplantrecipients
AT lawnancy evolutionofclinicalcareincovidinfectedsolidorgantransplantrecipients

Ejemplares similares